BRIEF published on 05/29/2024 at 15:19, 5 months 22 days ago Form 8.3 Disclosure: The Vanguard Group Inc. Involvement in Anglo American plc Takeover Code Vanguard Group Stock Market Shareholding Disclosure Anglo American
PRESS RELEASE published on 05/29/2024 at 15:14, 5 months 22 days ago Form 8.3 - The Vanguard Group, Inc.: Anglo American plc The Vanguard Group, Inc. discloses a 4.38% ownership in Anglo American plc through 58,535,227 ordinary securities. Purchase transactions were made at 25.56 GBP and 25.58 GBP per unit on 28 May 2024 The Vanguard Group Inc. Ownership Disclosure Stock Market Purchase Transactions Anglo American PLC
BRIEF published on 05/27/2024 at 15:37, 5 months 24 days ago Form 8.3 Disclosure by The Vanguard Group, Inc.: Anglo American plc Form 8.3 Takeover Code Securities Disclosure Vanguard Group Anglo American
PRESS RELEASE published on 05/27/2024 at 15:32, 5 months 24 days ago Form 8.3 - The Vanguard Group, Inc.: Anglo American plc The Vanguard Group, Inc. discloses a 4.38% interest in Anglo American plc. Dealings include purchase of USD 0.54945 ordinary shares Securities The Vanguard Group, Inc. Form 8.3 Disclosure Anglo American PLC
BRIEF published on 05/24/2024 at 16:17, 5 months 27 days ago Vanguard Group Discloses Position in Anglo American Plc Form 8.3 Takeover Code Vanguard Group Shareholding Disclosure Anglo American
PRESS RELEASE published on 05/24/2024 at 16:12, 5 months 27 days ago Form 8.3 - The Vanguard Group, Inc.: Anglo American plc The Vanguard Group, Inc. discloses a 4.38% interest in Anglo American plc as of 23 May 2024. Details of securities transactions also provided The Vanguard Group, Inc. Disclosure Interests Securities Transactions Anglo American PLC
BRIEF published on 05/23/2024 at 15:20, 5 months 28 days ago Vanguard Group Discloses Stake in Anglo American plc Form 8.3 Vanguard Group Stake Disclosure Anglo American PLC BHP Group Limited
PRESS RELEASE published on 05/23/2024 at 15:15, 5 months 28 days ago Form 8.3 - The Vanguard Group, Inc.: Anglo American plc The Vanguard Group, Inc. discloses a 4.38% interest in Anglo American plc as per Form 8.3 filing on 23 May 2024 The Vanguard Group, Inc. Form 8.3 Disclosure Anglo American PLC 4.38%
BRIEF published on 05/22/2024 at 14:54, 5 months 29 days ago Form 8.3 Disclosure: The Vanguard Group, Inc. on Anglo American plc Form 8.3 Disclosure Takeover Code Vanguard Anglo American
PRESS RELEASE published on 05/22/2024 at 14:49, 5 months 29 days ago Form 8.3 - The Vanguard Group, Inc.: Anglo American plc The Vanguard Group, Inc. discloses a 4.38% interest in Anglo American plc as of 21 May 2024, acquiring additional securities on that date The Vanguard Group Inc. Securities Acquisition Form 8.3 Disclosure Financial Interest Anglo American PLC
Published on 11/21/2024 at 14:15, 13 minutes ago neurocare Group AG Welcomes Kevin Reeder as Chief Financial Officer
Published on 11/21/2024 at 14:00, 28 minutes ago Demotech, Inc. Assigns a Financial Stability Rating(R) of A, Exceptional, to Steadily Insurance Company
Published on 11/21/2024 at 14:00, 28 minutes ago Montara Raises $5.4M to Help Organizations Deliver Better Data Products Faster
Published on 11/21/2024 at 14:00, 28 minutes ago Tevir Capital LP Ltd. Updates Early Warning Reporting in Respect of VerticalScope Holdings Inc.
Published on 11/21/2024 at 14:16, 12 minutes ago EQS-Adhoc: LM PAY S.A. Announces Third Quarter 2024 Preliminary Results and Updated Guidance
Published on 11/21/2024 at 14:15, 13 minutes ago ZenaTech Signs Blue UAS and NDAA Compliant Supply Chain Partners to Sell to US Defense Branches and NATO Forces
Published on 11/21/2024 at 12:35, 1 hour 53 minutes ago audius with successful third quarter 2024 - total revenue grows by +9.2% and EBITDA by +14.6
Published on 11/21/2024 at 06:58, 7 hours 30 minutes ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 19 hours 8 minutes ago Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 20 hours 43 minutes ago MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 20 hours 43 minutes ago Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
Published on 11/20/2024 at 07:45, 1 day 6 hours ago Gimv sells to Fremman Capital a majority stake in outpatient rehabilitation specialist rehaneo
